Miranda, Oshin
Kiehl, Sophie Marie
Qi, Xiguang
Brannock, M. Daniel
Kosten, Thomas
Ryan, Neal David
Kirisci, Levent
Wang, Yanshan
Wang, LiRong
Funding for this research was provided by:
Office of the Assistant Secretary of Defense for Health Affairs through the Alcohol and Substance Abuse Research Program (Award No. W81XWH-22-2-0081 (PASA3), Award No. W81XWH-22-2-0081 (PASA3), Award No. W81XWH-22-2-0081 (PASA3), Award No. W81XWH-22-2-0081 (PASA3), Award No. W81XWH-22-2-0081 (PASA3), Award No. W81XWH-22-2-0081 (PASA3))
Article History
Received: 6 March 2024
Accepted: 28 May 2024
First Online: 4 June 2024
Declarations
:
: This study was approved by the Institutional Review Board (IRB) of the University of Pittsburgh (STUDY19020153). The IRB determined that the proposed activity is not research involving human subjects as defined by U.S. Department of Health and Human Services (DHHS) and Food and Drug Administration (FDA) regulations. The need for informed consent to participate was waived by the IRB of the University of Pittsburgh.
: Not applicable.
: Neal David Ryan is the Treasurer, of the American Academy of Child and Adolescent Psychiatry and also a member of the Scientific Advisory Board of the Child Mind Institute. He reported a financial honorarium from the Scientific Advisory Board of the Child Mind Institute. Thomas R Kosten reports funding from the Department of Defense. LiRong Wang reports a sub-award from the Pharmacotherapies for Alcohol and Substance Use Disorders Alliance (PASA) funded by the Department of Defense. All other authors declare that they do not have any competing interest.